Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ASMB Assembly Biosciences Inc
- Stocks
- Healthcare
- NASDAQ: ASMB
Price (delayed)
$12.24
Market cap
$93.48M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$6.23
Enterprise value
$73.09M
Assembly Bio is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the
Highlights
ASMB's EPS is up by 41% year-on-year and by 7% since the previous quarter
Assembly Biosciences's net income has increased by 22% YoY
The company's debt has surged by 56% YoY but it fell by 2.2% QoQ
ASMB's quick ratio is down by 33% year-on-year and by 17% since the previous quarter
The equity has decreased by 19% from the previous quarter and by 17% YoY
Key stats
What are the main financial stats of ASMB
Market
Valuations
Earnings
Shares outstanding
7.64M
Market cap
$93.48M
Enterprise value
$73.09M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.38
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$76.79M
Net income
-$39.92M
EBIT
-$39.59M
EBITDA
-$39.46M
Free cash flow
-$56.21M
Per share
Balance sheet
Liquidity
EPS
-$6.23
EPS diluted
-$6.23
Free cash flow per share
-$7.49
Book value per share
$3.62
Revenue per share
$0
TBVPS
$13.19
Total assets
$99.02M
Total liabilities
$71.88M
Debt
$3.02M
Equity
$27.13M
Working capital
$48.9M
Debt to equity
0.11
Current ratio
2.05
Quick ratio
1.95
Net debt/EBITDA
0.52
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-36.8%
Return on equity
-131.8%
Return on invested capital
-101.3%
Return on capital employed
-75.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ASMB stock price
How has the Assembly Biosciences stock price performed over time
Intraday
4.97%
1 week
-13.68%
1 month
41.83%
1 year
-5.92%
YTD
-22.43%
QTD
28.03%
Financial performance
How have Assembly Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$76.79M
Net income
-$39.92M
Gross margin
N/A
Net margin
N/A
Assembly Biosciences's net income has increased by 22% YoY
Assembly Biosciences's operating income has decreased by 12% YoY and by 3.8% QoQ
Price vs fundamentals
How does ASMB's price correlate with its fundamentals
Growth
What is Assembly Biosciences's growth rate over time
Valuation
What is Assembly Biosciences stock price valuation
P/E
N/A
P/B
3.38
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ASMB's EPS is up by 41% year-on-year and by 7% since the previous quarter
The price to book (P/B) is 125% higher than the 5-year quarterly average of 1.5 and 17% higher than the last 4 quarters average of 2.9
The equity has decreased by 19% from the previous quarter and by 17% YoY
Efficiency
How efficient is Assembly Biosciences business performance
The company's return on assets rose by 33% YoY but it fell by 4.2% QoQ
The ROIC has decreased by 20% from the previous quarter
The return on equity has declined by 9% year-on-year and by 3.9% since the previous quarter
Dividends
What is ASMB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ASMB.
Financial health
How did Assembly Biosciences financials performed over time
The total assets is 38% more than the total liabilities
ASMB's quick ratio is down by 33% year-on-year and by 17% since the previous quarter
Assembly Biosciences's current ratio has decreased by 32% YoY and by 15% QoQ
The company's debt is 89% lower than its equity
The debt to equity has soared by 83% YoY and by 22% from the previous quarter
The company's debt has surged by 56% YoY but it fell by 2.2% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.